sur NANOBIOTIX (EPA:NANO)
Nanobiotix Announces Voting Rights and Shares Capital Update
Nanobiotix, a clinical-stage biotechnology company, has released updates concerning its voting rights and shares capital as of July 31, 2025. According to the latest figures, the company currently has 48,236,671 shares outstanding. The total number of theoretical voting rights stands at 50,340,736, while the exercisable voting rights are slightly lower at 50,318,618. This announcement follows the guidelines established by the French Commercial Code and the French Financial Markets Authority.
The company is listed on both Euronext Paris and Nasdaq, under the trading symbols NBTX and NANO.PA respectively. Nanobiotix continues its innovative work in biotechnology, centered around physics-based therapeutic approaches to improve treatment outcomes for patients worldwide.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NANOBIOTIX